Cargando…
Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660152/ http://dx.doi.org/10.1186/1745-6215-16-S2-P63 |